| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.944 | 15.335 | 23.691 | 27.619 | 67.989 | 51.297 |
| Total Income - EUR | - | - | - | - | 6.555 | 24.815 | 32.961 | 36.918 | 74.685 | 51.297 |
| Total Expenses - EUR | - | - | - | - | 9.139 | 22.075 | 10.130 | 16.149 | 29.777 | 44.650 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.585 | 2.740 | 22.830 | 20.769 | 44.908 | 6.647 |
| Net Profit/Loss - EUR | - | - | - | - | -2.640 | 2.571 | 22.120 | 19.940 | 44.228 | 6.134 |
| Employees | - | - | - | - | 2 | 1 | 1 | 2 | 0 | 1 |
Check the financial reports for the company - Sebaderm Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 15.922 | 23.358 | 20.666 | 19.440 | 18.814 | 54.028 |
| Current Assets | - | - | - | - | 10.027 | 3.846 | 18.260 | 30.710 | 6.442 | 1.366 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 20 | 0 | 3.906 | 260 |
| Cash | - | - | - | - | 10.027 | 3.846 | 18.240 | 30.710 | 2.536 | 1.106 |
| Shareholders Funds | - | - | - | - | -2.597 | 23 | 22.142 | 42.151 | 23.929 | 824 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.971 | 1.374 | 820 | 1.284 | 1.327 | 54.570 |
| Income in Advance | - | - | - | - | 26.574 | 25.807 | 15.965 | 6.716 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sebaderm Medical S.r.l.